We are live on
!
Find out more
VCG
Vantage Consulting Group Portfolio holdings
AUM
$19.7M
1-Year Est. Return
280.87%
This Fund
S&P 500
This Quarter
Est. Return
+17.65%
1 Year Est. Return
+280.87%
3 Year Est. Return
+261.08%
5 Year Est. Return
+180.34%
10 Year Est. Return
–
AUM
$1.23B
AUM Growth
–
Cap. Flow
+$1.06B
Cap. Flow
% of AUM
86.51%
Top 10 Holdings %
Top 10 Hldgs %
94.5%
Holding
1,884
New
1,883
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$911M |
| 2 |
ADC Therapeutics
ADCT
|
+$55.1M |
| 3 |
KYNB
Kyntra Bio
KYNB
|
+$25.5M |
| 4 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$5.96M |
| 5 |
Kroger
KR
|
+$366K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 95.04% |
| 2 | Technology | 0.89% |
| 3 | Consumer Discretionary | 0.79% |
| 4 | Industrials | 0.61% |
| 5 | Consumer Staples | 0.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Cincinnati Financial
CINF
$27.3B
| $102K | 0.01% |
+1,172
| New | +$93.5K |
|
177
Chesapeake Utilities
CPK
$3.19B
| $102K | 0.01% |
+939
| New | +$94.1K |
|
178
California Water Service
CWT
$3.1B
| $102K | 0.01% |
+1,896
| New | +$93.4K |
|
|
HBI
179
DELISTED
Hanesbrands
HBI
| $102K | 0.01% |
+7,007
| New | +$106K |
|
180
Tapestry
TPR
$30.8B
| $102K | 0.01% |
+3,283
| New | +$83.1K |
|
181
Clearwater Paper
CLW
$339M
| $101K | 0.01% |
+2,681
| New | +$100K |
|
182
Plexus
PLXS
$6.72B
| $101K | 0.01% |
+1,288
| New | +$96.1K |
|
183
J.M. Smucker
SJM
$12.7B
| $101K | 0.01% |
+875
| New | +$102K |
|
|
CMA
184
DELISTED
Comerica
CMA
| $100K | 0.01% |
+1,796
| New | +$87.6K |
|
185
Walt Disney
DIS
$167B
| $100K | 0.01% |
+554
| New | +$79.5K |
|
186
General Mills
GIS
$19.1B
| $100K | 0.01% |
+1,699
| New | +$103K |
|
187
OneSpan
OSPN
$574M
| $100K | 0.01% |
+4,846
| New | +$104K |
|
188
eHealth
EHTH
$42.2M
| $99K | 0.01% |
+1,398
| New | +$106K |
|
189
Zions Bancorporation
ZION
$10.2B
| $99K | 0.01% |
+2,272
| New | +$84K |
|
190
Nike
NKE
$61.9B
| $98K | 0.01% |
+696
| New | +$92.2K |
|
|
PARA
191
DELISTED
Paramount Global Class B
PARA
| $98K | 0.01% |
+2,625
| New | +$84.2K |
|
192
Sanmina
SANM
$9.95B
| $98K | 0.01% |
+3,084
| New | +$91.5K |
|
193
Travelers Companies
TRV
$78.1B
| $98K | 0.01% |
+700
| New | +$89.9K |
|
194
Ralph Lauren
RL
$22.6B
| $97K | 0.01% |
+936
| New | +$78.5K |
|
195
W.R. Berkley
WRB
$26.9B
| $97K | 0.01% |
+3,269
| New | +$94.3K |
|
|
DBD
196
DELISTED
Diebold Nixdorf Incorporated
DBD
| $97K | 0.01% |
+9,126
| New | +$82.9K |
|
197
Everest Group
EG
$14.5B
| $96K | 0.01% |
+410
| New | +$90.5K |
|
|
TIF
198
DELISTED
Tiffany & Co.
TIF
| $96K | 0.01% |
+734
| New | +$94K |
|
199
Rollins
ROL
$18.3B
| $95K | 0.01% |
+2,426
| New | +$94K |
|
|
VG
200
DELISTED
Vonage Holdings Corporation
VG
| $95K | 0.01% |
+7,397
| New | +$90K |
|
Similar funds
MVG
NCM
FFGIM
PIM
HFG
SWM
ICM
SM
Vantage Consulting Group's Q4 2020 Portfolio in Review
Q4 2020 is the first quarter with a 13F filing on record for Vantage Consulting Group, which disclosed 1,884 positions worth $1.23B. Its ten largest holdings account for 94% of the portfolio.
Its largest position is Royalty Pharma: 21,477,282 shares worth $1.07B.
By sector, the portfolio is most concentrated in Healthcare at 95% of assets, followed by Technology and Consumer Discretionary.
- Vantage Consulting Group's largest Q4 2020 buy was Royalty Pharma: 21,477,282 shares worth $1.07B.
- Vantage Consulting Group's ten largest holdings make up 94% of its $1.23B portfolio in Q4 2020.
- Vantage Consulting Group disclosed 1,884 positions in Q4 2020, its first 13F filing on record.
Based on Vantage Consulting Group's 13F filing for Q4 2020, filed 12 Feb 2021.